Letter to the Editor: Choosing an Anticoagulant in Patients With APS | ASH Clinical News | American Society of Hematology
In the December 2023 issue of “You Make the Call,” Shruti Chaturvedi, MBBS, MS, discussed treatment options for a female patient presenting with a left cerebrovascular accident likely due to contraceptive use and positive antiphospholipid antibodies (APLAs), with a recommendation for warfarin and aspirin therapy. Following the publication of four randomized trials of direct oral anticoagulants (DOACs) versus warfarin in patients with antiphospholipid syndrome (APS), there has been greater insecurity in